Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heart Yin deficiency is **not a molecular target or receptor** but rather a diagnostic pattern in Traditional Chinese Medicine (TCM). It describes an imbalance where the nourishing and calming "Yin" aspect of the heart is insufficient. This leads to symptoms such as palpitations, insomnia, restlessness, night sweats, heat sensations (especially in the palms and soles), dry mouth and throat, poor memory, anxiety, and dream-disturbed sleep[1][6][7]. In TCM theory, this pattern can arise from chronic emotional stress, overwork without adequate rest or nourishment, prolonged illness depleting body fluids or blood (which are considered forms of "Yin"), or aging[3][5][7]. Heart Yin deficiency is often associated with other patterns like Kidney Yin deficiency or Heart Blood deficiency. It does not correspond to any specific protein/receptor/enzyme/transporter recognized in biomedical science; instead it represents a holistic syndrome used for guiding herbal prescriptions and acupuncture point selection within TCM practice[2][4][7]. There are no drugs that directly interact with "Heart Yin" as it is not a molecule but some herbal formulas—such as Tian Wang Bu Xin Dan—are traditionally used to address this pattern by nourishing heart yin and calming the mind[7]. Because "Heart Yin deficiency" refers to a syndrome/pattern rather than an identifiable molecular entity: - **It should not be classified as a therapeutic target**. - **It cannot be mapped onto standard molecular classifications**. - **There are no known biomarkers or direct safety concerns related to targeting it**, though improper treatment based on misdiagnosis could pose risks. In summary: - The term “Heart Yin deficiency” reflects traditional diagnostic language from Chinese medicine describing functional imbalances—not a discrete biological molecule suitable for drug targeting. Therefore its inclusion as a “target” is incorrect in modern pharmacological contexts[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heart Yin deficiency.